The home-based care provider Compassus has appointed Michael J. Asselta as its new CEO, succeeding David Grams.

Prior to joining Compassus, Asselta spent eight years with Massachusetts-based Fresenius Medical Care North America, where he most recently served as COO of U.S. Care Delivery and president of Fresenius Kidney Care. There, he managed more than 60,000 employees and 4,000 care delivery locations.

“Mike has an impressive track record of operating and growing multi-site health care service organizations that provide the highest quality of care, and I am confident he is the right person to lead Compassus as it continues to broaden access to integrated, home-based care services in partnership with market-leading health systems and payor organizations,” said Compassus Executive Chairman Pat Ryan in a statement. “Mike’s experience driving operational excellence at scale and employer-of-choice initiatives will be a tremendous asset in advancing these goals. On behalf of the board of directors and the company.”

Asselta also previously held c-suite positions in both public and private health care companies, including LabOne, Quest Diagnostics and SelectQuote Senior.

Grams will remain with the company temporarily in an advisory capacity to ensure a seamless transition. He took the helm at the Compassus in 2022.

A portfolio company of the private equity firm Towerbrook Capital Partners and the health system Ascension Health, Compassus provides a continuum of home-based services including home health, home infusion, palliative care and hospice from more than 250 locations across 29 states.

“Compassus has a strong reputation for excellence and high-quality, home-based care across the country, which continues to be realized through its integrated care model and growth in market-leading partnerships,” Asselta said in a statement. “I am honored to have the opportunity to lead the organization into this next phase alongside a highly accomplished management team of passionate and compassionate leaders.”